Jun. 29 at 7:57 PM
$META
The valuation argument is strong on paper: lower multiple vs mega-cap peers, faster growth, and solid cash generation. That’s the bull case in a nutshell.
But the market usually doesn’t misprice names like META just on headline P/E. It re-rates based on durability of growth, capex cycle (AI spend), and whether margins stay stable while they invest heavily.
At ~16x forward earnings, yes it screens cheap relative to
$AAPL /
$MSFT /
$AMZN, but “cheap” can stay cheap if sentiment + capital allocation uncertainty keeps a discount in place.
So this isn’t a “why wouldn’t it work” setup, it’s a “what has to prove itself next” setup: sustained AI monetization + ad strength + disciplined spend.
If those hold, re-rating is logical. If not, valuation alone won’t save it.
What matters more to you here — valuation gap or execution risk?
